Grant Opportunities
Research on Autism Spectrum Disorders (R21) – May 07, 2016
Home » Research on Autism Spectrum Disorders (R21) – May 07, 2016
…
| Funding Opportunity Number: |
PA-13-217 |
| Opportunity Category: |
Discretionary |
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Environment
Health
Income Security and Social Services |
| CFDA Number: |
93.113
93.173
93.242
93.853
93.865 |
| Eligible Applicants |
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Agency Name: |
HHS-NIH11 |
| Closing Date: |
May 07, 2016 |
| Award Ceiling: |
$200,000 |
| Expected Number of Awards: |
|
| Creation Date: |
May 01, 2013 |
| Funding Opportunity Description: |
This Funding Opportunity Announcement (FOA) encourages research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. The R21 grant mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on biomedical, behavioral, or clinical research. |
|
Read more
